ESDF to reactivate medicine production within Libya through its Bosnian Bosnalijek pharmaceutical investment
By Sami Zaptia.
London, 28 May 2021:
Libya’s Economic and Social Development Fund (ESDF) revealed that it is to reactivate medicine production within Libya.
The ESDF announced the news yesterday after it participated in the meetings of the General Assembly of the Bosnian Pharmaceutical Industry Company, Bosnalijek, in the Bosnian capital, Sarajevo.
The ESDF owns a 7.6 percent share in Bosnalijek.
The ESDF said it attended the Sarajevo meeting within the framework of following-up on its foreign investments.
It reported that during the meeting the approval of the General Assembly for investment in the pharmaceutical industry in Libya was obtained, which it added will contribute to the return of the pharmaceutical industry inside Libya.
Several other decisions presented to the company’s General Assembly were also taken.
The ESDF said Bosnalijek is considered one of its successful foreign investments, and which, if developed, will enhance the financial position of the fund.